FDA Approves POKONZA POTASSIUM CHLORIDE — Carwin Pharmaceutical Associates, LLC
Carwin Pharmaceutical Associates, LLC received FDA clearance for its potassium chloride oral formulation POKONZA, a move expected to expand generic supply and increase market competition in the potassium supplementation sector.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day